EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight

Katy M Toale, Claire A Marten, Ashley Crouch, Clark R Andersen, Fauzia Ullah, Cristhiam Mauricio Rojas Hernandez

Journal of Thrombosis and Thrombolysis · 06.03.2026 · 59 (5) · 1091-1102

DOI: 10.1007/s11239-026-03239-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 06.03.2026. Verfasst von Katy M Toale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Quality and Regulatory, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 90, Houston, TX, 77030, USA…. Hauptthemen laut MEDLINE: Heparin, Low-Molecular-Weight, Venous Thromboembolism, Neoplasms, Anticoagulants. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heparin, Low-Molecular-WeightVenous ThromboembolismNeoplasmsAnticoagulantsBody WeightHumansFemaleMaleRetrospective StudiesAdministration, OralMiddle AgedHemorrhageAgedTreatment OutcomeRecurrenceAdult

Stichwörter der Autor:innen

Cancer associated thrombosisDirect oral anticoagulantsExtreme weightsLow molecular weight heparinObesityUnderweight

Substanzen

Heparin, Low-Molecular-WeightAnticoagulants

Autor:innen und Institutionen

  • Department of Pharmacy Quality and Regulatory, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 90, Houston, TX, 77030, USA. khanzelka@mdanderson.org.
  • Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Förderung

  • National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant

Zitieren

APA

Toale, K. M., Marten, C. A., Crouch, A., Andersen, C. R., Ullah, F., & Rojas Hernandez, C. M. (2026). Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight. Journal of Thrombosis and Thrombolysis, 59(5), 1091-1102. https://doi.org/10.1007/s11239-026-03239-x

Vancouver

Toale KM, Marten CA, Crouch A, Andersen CR, Ullah F, Rojas Hernandez CM. Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight. Journal of Thrombosis and Thrombolysis. 2026;59(5):1091-1102. doi:10.1007/s11239-026-03239-x

BibTeX
@article{Toale2026,
  author = {Toale, Katy M and Marten, Claire A and Crouch, Ashley and Andersen, Clark R and Ullah, Fauzia and Rojas Hernandez, Cristhiam Mauricio},
  title = {Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2026},
  volume = {59},
  number = {5},
  pages = {1091--1102},
  doi = {10.1007/s11239-026-03239-x}
}
Kostenlos starten →